DNLI
Price
$15.04
Change
+$0.09 (+0.60%)
Updated
Mar 11 closing price
Capitalization
2.18B
62 days until earnings call
MLTX
Price
$37.74
Change
+$0.99 (+2.69%)
Updated
Mar 11 closing price
Capitalization
2.38B
57 days until earnings call
Ad is loading...

DNLI vs MLTX

Header iconDNLI vs MLTX Comparison
Open Charts DNLI vs MLTXBanner chart's image
Denali Therapeutics
Price$15.04
Change+$0.09 (+0.60%)
Volume$1.75M
Capitalization2.18B
MoonLake Immunotherapeutics
Price$37.74
Change+$0.99 (+2.69%)
Volume$356.28K
Capitalization2.38B
DNLI vs MLTX Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. MLTX commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Hold and MLTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (DNLI: $15.04 vs. MLTX: $37.67)
Brand notoriety: DNLI and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 154% vs. MLTX: 85%
Market capitalization -- DNLI: $2.18B vs. MLTX: $2.38B
DNLI [@Biotechnology] is valued at $2.18B. MLTX’s [@Biotechnology] market capitalization is $2.38B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 0 green, 5 red.
According to our system of comparison, MLTX is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 4 TA indicator(s) are bullish while MLTX’s TA Score has 4 bullish TA indicator(s).

  • DNLI’s TA Score: 4 bullish, 6 bearish.
  • MLTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а -5.71% price change this week, while MLTX (@Biotechnology) price change was -6.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.43%. For the same industry, the average monthly price growth was -8.50%, and the average quarterly price growth was -7.70%.

Reported Earning Dates

DNLI is expected to report earnings on May 13, 2025.

MLTX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+0.43% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($2.38B) has a higher market cap than DNLI($2.18B). DNLI YTD gains are higher at: -26.202 vs. MLTX (-30.443). MLTX has higher annual earnings (EBITDA): -108.45M vs. DNLI (-496.05M). DNLI has more cash in the bank: 837M vs. MLTX (494M). MLTX has less debt than DNLI: MLTX (3.69M) vs DNLI (52.5M). DNLI (0) and MLTX (0) have equivalent revenues.
DNLIMLTXDNLI / MLTX
Capitalization2.18B2.38B92%
EBITDA-496.05M-108.45M457%
Gain YTD-26.202-30.44386%
P/E RatioN/AN/A-
Revenue00-
Total Cash837M494M169%
Total Debt52.5M3.69M1,424%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIMLTX
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
60%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
56%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
54%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 20 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
79%
Bearish Trend 3 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
55%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LDMIX13.720.05
+0.37%
Lazard Developing Markets Equity Instl
BABDX12.13N/A
N/A
BlackRock Global Dividend Inv A
DTGRX56.11N/A
N/A
BNY Mellon Technology Growth A
SCRLX68.52N/A
N/A
Touchstone Large Cap Focused Instl
RSLBX53.53-0.01
-0.02%
American Funds SMALLCAP World R2

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with RGNX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+0.60%
RGNX - DNLI
54%
Loosely correlated
+1.66%
RCKT - DNLI
52%
Loosely correlated
-4.54%
NTLA - DNLI
52%
Loosely correlated
-1.64%
BEAM - DNLI
52%
Loosely correlated
+2.82%
CRSP - DNLI
51%
Loosely correlated
-2.19%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XENE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+2.49%
XENE - MLTX
42%
Loosely correlated
+1.50%
AKBA - MLTX
39%
Loosely correlated
+3.76%
DNLI - MLTX
36%
Loosely correlated
+0.60%
CLDX - MLTX
36%
Loosely correlated
+4.81%
ATXS - MLTX
36%
Loosely correlated
+11.34%
More